1-3 of 3
Jessica Shafer, MD
Close
Sort by
Journal Articles

The Histone Deacetylase (HDAC) Inhibitor Entinostat (SNDX-275) Targets Hodgkin Lymphoma through a Dual Mechanism of Immune Modulation and Apoptosis Induction.

Noor M Khaskhely, MD, PhD, Daniela Buglio, MD, Jessica Shafer, MD, Catherine M. Bollard, MD, FRACP, FRCPA, Anas Younes, MD
Journal: Blood
Blood (2009) 114 (22): 1562.
https://doi.org/10.1182/blood.V114.22.1562.1562
Published: 2009
Journal Articles

Immune-Based Therapies Targeting Mage-A4 for Relapsed/Refractory Hodgkin's Lymphoma After Stem Cell Transplant.

Conrad Russell Y. Cruz, MD, Ann M. Leen, PhD, Ulrike Gerdemann, MD, Anne S. Christin, MD, Tamara Tripic, PhD, Jessica Shafer, MD, Anas Younes, MD, Terzah M. Horton, MD, PhD, Elizabeth J. Shpall, MD, Helen E. Heslop, MD, Cliona M. Rooney, PhD, Catherine M. Bollard, MD, FRACP, FRCPA
Journal: Blood
Blood (2009) 114 (22): 4089.
https://doi.org/10.1182/blood.V114.22.4089.4089
Published: 2009
Journal Articles

Selective Loss of a Putative Precursor Population of B-Chronic Lymphocytic Leukemia Cells Following Immunization with hCD40L/IL-2 Expressing Autologous Tumor Cells

Aaron Foster, PhD, Fatma Okur, MD, Gianpietro Dotti, MD, Jessica Shafer, MD, An Lu, Ettore Biagi, Eric Yvon, Catherine M Bollard, MD, Barbara Savoldo, MD, Michael Andreeff, MD, PhD, Margaret A Goodell, PhD, Cliona M Rooney, PhD, Malcolm K Brenner, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3172.
https://doi.org/10.1182/blood.V112.11.3172.3172
Published: 2008